NYT: Biotech C-Suite Execs Targeted By Sophisticated Email Hackers -- At "Fin4"

Previously known to have concentrated only on executives in the financial services industry, it seems that at least a few CEOs, CFOs and EVP GCs were duped -- in the life sciences sector, as well. The hackers seem to have deep i-banking chops. Rather alarming, no?

The material inside information -- market moving information, that is -- in such executives' email inboxes, would be legion. Do go read the whole New York Times piece, but here's a bit:

. . . .FireEye would not name the victims, citing nondisclosure agreements with its clients, but said that all but three of the affected organizations are publicly listed on the New York Stock Exchange or Nasdaq, while the others are listed on exchanges outside the United States.

Half of these companies fall into the biotechnology sector; 13 percent sell medical devices; 12 percent sell medical instruments and equipment; 10 percent manufacture drugs; and a small minority of targets include medical diagnostics and research organizations, health care providers and organizations that offer health care planning services. . . .

So, be careful out there. Happy Cyber-Monday. . . click and shop wisely.